The true measure of an AI-native ambulatory heart rhythm program isn’t found in marketing claims, but in the documented record of its underlying data…
The narrative around AI-native healthcare startups often begins with market potential and innovative claims. However, for those tracking AI-native ventures and clinical validation, a…
The distinction between an AI-native diagnostic platform and one retrofitted with artificial intelligence capabilities is not found in marketing narratives, but in the documented…
The field of AI in healthcare is often obscured by enthusiastic headlines and aspirational claims. For clinicians and technology evaluators seeking to understand what…
The article has been reviewed for time-sensitive claims. The key principles of FDA Good Machine Learning Practice (GMLP) outlined in the article remain consistent…
What Makes a Health Company Truly AI-Native?
What Makes a Health Company Truly AI-Native?
What Makes a Health Company Truly AI-Native?
What Makes a Health Company Truly AI-Native?
What Makes a Health Company Truly AI-Native?
What Makes a Health Company Truly AI-Native?
Algorithmic brilliance is useless if it is trapped outside the clinician’s daily Electronic Health Record (EHR) workflow. For venture capitalists evaluating the burgeoning cardiac AI…
Read More
The field of cardiac artificial intelligence is undergoing a deep transformation, moving beyond the foundational yet increasingly commoditized area of simple ECG interpretation. The true…
Read More
Automated coronary artery disease diagnostics represent one of the most well-funded and clinically validated sectors in digital health. By automating the analysis of coronary CT…
Read More
The decades-long reign of static risk calculators in cardiology is rapidly drawing to a close. A new model, driven by dynamic machine learning (ML) models,…
Read More
